EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

17⍺-Estradiol Protects against HIV-1 Tat-Induced Endolysosome Dysfunction and Dendritic Impairments in Neurons

Gaurav Datta iD, Nicole M Miller, Xuesong Chen

Cells · 2023

DOI: 10.3390/cells12050813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2023. Verfasst von Gaurav Datta und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58203, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV Seropositivity, HIV-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HIV-1 Tat continues to play an important role in the development of HIV-associated neurocognitive disorders (HAND), which persist in 15–55% of people living with HIV even with virological control. In the brain, Tat is present on neurons, where Tat exerts direct neuronal damaging effects by, at least in part, disrupting endolysosome functions, a pathological feature present in HAND. In this study, we determined the protective effects of 17α-estradiol (17αE2), the predominant form of estrogen in the brain, against Tat-induced endolysosome dysfunction and dendritic impairment in primary cultured hippocampal neurons. We demonstrated that pre-treatment with 17αE2 protected against Tat-induced endolysosome dysfunction and reduction in dendritic spine density. Estrogen receptor alpha (ERα) knockdown impairs the ability of 17αE2 to protect against Tat-induced endolysosome dysfunction and reduction in dendritic spine density. Furthermore, over-expressing an ERα mutant that fails to localize on endolysosomes impairs 17αE2′s protective effects against Tat-induced endolysosome dysfunction and reduction in dendritic spine density. Our findings demonstrate that 17αE2 protects against Tat-induced neuronal injury via a novel ERα-mediated and endolysosome-dependent pathway, and such a finding might lead to the development of novel adjunct therapeutics against HAND.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsHIV SeropositivityHIV-1HumansEstradiolEstrogen Receptor alphaNeuronstat Gene Products, Human Immunodeficiency Virus

Stichwörter der Autor:innen

17α-estradiolHIV-1 Tatdendritic spineendolysosomesestrogen receptors alpha

Substanzen

EstradiolEstrogen Receptor alphatat Gene Products, Human Immunodeficiency Virus

Autor:innen und Institutionen

  • Department of Biomedical Sciences, University of North Dakota School of Medicine and Health Sciences, Grand Forks, ND 58203, USA.

ORCID-Profile: Gaurav Datta

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Datta, G., Miller, N. M., & Chen, X. (2023). 17⍺-Estradiol Protects against HIV-1 Tat-Induced Endolysosome Dysfunction and Dendritic Impairments in Neurons. Cells. https://doi.org/10.3390/cells12050813

Vancouver

Datta G, Miller NM, Chen X. 17⍺-Estradiol Protects against HIV-1 Tat-Induced Endolysosome Dysfunction and Dendritic Impairments in Neurons. Cells. 2023. doi:10.3390/cells12050813

BibTeX
@article{Datta2023,
  author = {Datta, Gaurav and Miller, Nicole M and Chen, Xuesong},
  title = {17⍺-Estradiol Protects against HIV-1 Tat-Induced Endolysosome Dysfunction and Dendritic Impairments in Neurons},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12050813}
}
Kostenlos starten →